Syngene International plans to invest $200 million for expansion

23 Feb 2016 Evaluate

In a bid to expand capacity and upgrade manufacturing facilities, Syngene International is planning to invest $200 million over the next two years.

The investment areas for the capital expenditure are research centre, formulation centre, manufacturing facilities and expansion of new capabilities. The company will tap a mixture of its own resources and debt to raise funds for future growth. Future funding requirements will be met through internal accruals and debt.

Syngene International offers discovery and development services for novel molecular entities (NMEs) across industrial sectors including pharmaceutical, biotechnology, agrochemicals, consumer health, animal health, cosmetic and nutrition.

Syngene Internation. Share Price

862.60 2.75 (0.32%)
01-Nov-2024 18:59 View Price Chart
Peers
Company Name CMP
Syngene Internation. 862.60
AGS Transact Tech 96.36
Just Dial 1141.00
Krystal Integrated 716.70
Latent View Analytic 461.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.